COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

Autor: Lennard Y.W. Lee, Maria C. Ionescu, Thomas Starkey, Martin Little, Michael Tilby, Arvind R. Tripathy, Hayley S. Mckenzie, Youssra Al-Hajji, Nathan Appanna, Matthew Barnard, Liza Benny, Alexander Burnett, Emma L. Cattell, James J. Clark, Sam Khan, Qamar Ghafoor, Hari Panneerselvam, George Illsley, Catherine Harper-Wynne, Rosie J. Hattersley, Alvin JX. Lee, Oliver Lomas, Justin KH. Liu, Amanda McCauley, Matthew Pang, Jennifer S. Pascoe, James R. Platt, Grisma Patel, Vijay Patel, Vanessa A. Potter, Amelia Randle, Anne S. Rigg, Tim M. Robinson, Tom W. Roques, René L. Roux, Stefan Rozmanowski, Harriet Taylor, Mark H. Tuthill, Isabella Watts, Sarah Williams, Andrew Beggs, Tim Iveson, Siow M. Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Matthew W. Fittall, Tom Fowler, Peter Johnson, Emma Kinloch, Emily Lam, Gillian Murphy, Malcolm Rhodes, Kate Robinson, Sanskriti Swarup, Keeley Bernhardt, Jola Bytyci, Yuxin Ying, Sukhmunni Johal, Remarez Sheehan

Publikováno v: European journal of cancer (Oxford, England : 1990). 175

People living with cancer and haematological malignancies are at an increased risk of hospitalisation and death following infection with acute respiratory syndrome coronavirus 2. Coronavirus third dose vaccine boosters are proposed to boost waning im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b456df6d584137078ec70d3485af98d8
https://pubmed.ncbi.nlm.nih.gov/36084618

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

Autor: Lennard Y W Lee, Thomas Starkey, Maria C Ionescu, Martin Little, Michael Tilby, Arvind R Tripathy, Hayley S Mckenzie, Youssra Al-Hajji, Matthew Barnard, Liza Benny, Alexander Burnett, Emma L Cattell, Jackie Charman, James J Clark, Sam Khan, Qamar Ghafoor, George Illsley, Catherine Harper-Wynne, Rosie J Hattersley, Alvin J X Lee, Pauline C Leonard, Justin K H Liu, Matthew Pang, Jennifer S Pascoe, James R Platt, Vanessa A Potter, Amelia Randle, Anne S Rigg, Tim M Robinson, Tom W Roques, René L Roux, Stefan Rozmanowski, Mark H Tuthill, Isabella Watts, Sarah Williams, Tim Iveson, Siow Ming Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Matthew W Fittall, Tom Fowler, Peter Johnson, Emma Kinloch, Emily Lam, Gillian Murphy, Malcolm Rhodes, Kate Robinson

Publikováno v: Lee, L Y W, Starkey, T, Ionescu, M C, Little, M, Robinson, T & Tilby, M 2022, ' Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP) : a population-based test-negative case-control study ', Lancet Oncology, vol. 23, no. 6, pp. 748-757 . https://doi.org/10.1016/S1470-2045(22)00202-9

Background People with cancer are at increased risk of hospitalisation and death following infection with SARS-CoV-2.Therefore, we aimed to conduct one of the first evaluations of vaccine effectiveness against breakthroughSARS-CoV-2 infections in pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39c40db3708d40aa264397f59fb5944
https://pubmed.ncbi.nlm.nih.gov/35617990

Contributors

Autor: Arfa Ahmed, Ekua Annobil, Aria Campbell-Danesh, Caroline Deodhar, Adam Douglas, Emmajane Down, Ellen Fallows, Liz Forty, Farah Gilani, Laura Gush, Athanasios Hassoulas, Saba Jaleel, Lorna Jeng, Alexandra J. Kermack, Liza Kirtchuk, Emma Ladds, Devina Leopold, Nita Maha, Hayley S. McKenzie, Anjaly Mirchandani, Gemma Newman, Alka Patel, Venita Patel, Thom Phillips, Carolyn Rubens, Sonal Shah, Laura Sheldrake, Emma Short, Ailsa Sita-Lumsden, Claire Stansfield, Ann Wylie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9e9b9c9fb3c95094dddfbe9178bf7639
https://doi.org/10.1016/b978-0-12-821573-9.01002-x

How I treat advanced classical Hodgkin lymphoma

Autor: Hayley S McKenzie, Peter Johnson

Publikováno v: Blood. 125:1717-1723

The development of curative systemic treatment of Hodgkin lymphoma was recently voted one of the top 5 achievements of oncology in the last 50 years (http://cancerprogress.net/top-5-advances-modern-oncology). The high expectation of cure (above 80%)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab51f6366f12d46357bae95943b63e77
https://doi.org/10.1182/blood-2014-09-551556

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study

Autor: Hayley S McKenzie, Ruth Pettengell, Louise Stanton, John Radford, Peter Johnson, Andrew Davies, Caroline Dive, Timothy M Illidge, Grace Hampson, Andrew Bates, Sam Mayes, Maureen A. Zivanovic, Jill Tipping, Eve Gallop-Evans, Kelly Cozens

Publikováno v: British journal of haematology. 173(2)

Summary We report a phase II study to evaluate the efficacy and toxicity of abbreviated immunochemotherapy followed by 90Y Ibritumomab tiuxetan (90Y-IT) in patients with recurrent follicular lymphoma. Of the 52 patients enrolled, 50 were treated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ed5d5b9c05093b160663a95a58f2ee
https://pubmed.ncbi.nlm.nih.gov/26849853